Search Results - "Zha, Jiandong"

Successful administration of cetuximab using dose escalation method: a case report by Li, Shasha, Zhang, Yanjuan, Zha, Jiandong, Chen, Wenqi

“…Cetuximab, used to treat head and neck squamous cell carcinoma and metastatic colorectal cancer, can cause severe infusion reactions. We report an 87-year-old…”
Get full text

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin by Xu, Zhiyuan, Yang, Li, Ng, Wai-Tong, Helali, Aya El, Lee, Victor Ho-Fun, Ma, Lingyu, Liu, Qin, Li, Jishi, Shen, Lin, Huang, Jijie, Zha, Jiandong, Zhou, Cheng, Lee, Anne W M, Chen, Longhua

“…We conducted this study to evaluate if a reduced cumulative dose of induction and concurrent cisplatin conferred similar favorable outcomes when compared to…”
Get full text

An investigation on acquired mutations after TKI treatment in Chinese lung cancer patients by Jiang, Yong, Li, Yingmei, Zha, Jiandong, Liu, Danni, Kong, Feng-Ming Spring

“…Abstract only e21162 Background: Targeted therapy has greatly extended the survival of certain molecular selected cancer patients. However, lots of them would…”
Get full text

Potential value of detection of minimal residual disease in colorectal cancer following radical resection by Pu, Wenji, Chen, Fang, Tang, Yuan, Qu, Yanling, Han, Yunzhu, Zha, Jiandong, Jin, Jing, Kong, Fengming

“…Although there has been significant advancement in the identification and management of colorectal cancer (CRC) in recent years, there is still room for…”
Get full text

GOLM1 affects proliferation, invasion, and migration by regulating Wnt pathway in esophageal squamous cell carcinoma cells by Liu, Yaya, Zhang, Jinliang, Xiao, Min, Zha, Jiandong, Fu, Yanqiu, Wei, Changyu, Tang, Jun

“…To investigate the effect of Golgi membrane protein 1 (GOLM1) on the proliferation, migration, and invasion of esophageal squamous cell carcinoma (ESCC) cells…”
Get full text

Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer by Yang, Li, Xu, Zhiyuan, Ma, Lingyu, Liu, Qin, Chang, Amy T Y, Wang, Qian, Zha, Jiandong, Zhang, Jinliang, Jiang, Xiaoqin, Zhang, Jingjing, Kong, Feng-Ming Spring, Guo, Linlang

“…Lymphopenia during definitive radiotherapy (RT) has been shown to reduce survival in patients with cervical cancer. However, there are few studies on the…”
Get more information